248 related articles for article (PubMed ID: 32258408)
1. Targeted gene silencing in vivo by platelet membrane-coated metal-organic framework nanoparticles.
Zhuang J; Gong H; Zhou J; Zhang Q; Gao W; Fang RH; Zhang L
Sci Adv; 2020 Mar; 6(13):eaaz6108. PubMed ID: 32258408
[TBL] [Abstract][Full Text] [Related]
2. Enhanced lysosomal escape of cell penetrating peptide-functionalized metal-organic frameworks for co-delivery of survivin siRNA and oridonin.
Cai M; Yao Y; Yin D; Zhu R; Fu T; Kong J; Wang K; Liu J; Yao A; Ruan Y; Shi W; Zhu Q; Ni J; Yin X
J Colloid Interface Sci; 2023 Sep; 646():370-380. PubMed ID: 37207419
[TBL] [Abstract][Full Text] [Related]
3. A biomimetic camouflaged metal organic framework for enhanced siRNA delivery in the tumor environment.
Tao T; Rehman SU; Xu S; Zhang J; Xia H; Guo Z; Li Z; Ma K; Wang J
J Mater Chem B; 2024 May; 12(17):4080-4096. PubMed ID: 38577851
[TBL] [Abstract][Full Text] [Related]
4. Self-Assembly of Extracellular Vesicle-like Metal-Organic Framework Nanoparticles for Protection and Intracellular Delivery of Biofunctional Proteins.
Cheng G; Li W; Ha L; Han X; Hao S; Wan Y; Wang Z; Dong F; Zou X; Mao Y; Zheng SY
J Am Chem Soc; 2018 Jun; 140(23):7282-7291. PubMed ID: 29809001
[TBL] [Abstract][Full Text] [Related]
5. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy.
Xu C; Liu W; Hu Y; Li W; Di W
Theranostics; 2020; 10(7):3325-3339. PubMed ID: 32194871
[TBL] [Abstract][Full Text] [Related]
6. Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice.
Luan X; Rahme K; Cong Z; Wang L; Zou Y; He Y; Yang H; Holmes JD; O'Driscoll CM; Guo J
Eur J Pharm Biopharm; 2019 Apr; 137():56-67. PubMed ID: 30779980
[TBL] [Abstract][Full Text] [Related]
7. Platelet membrane-camouflaged silver metal-organic framework drug system against infections caused by methicillin-resistant Staphylococcus aureus.
Huang R; Cai GQ; Li J; Li XS; Liu HT; Shang XL; Zhou JD; Nie XM; Gui R
J Nanobiotechnology; 2021 Aug; 19(1):229. PubMed ID: 34348721
[TBL] [Abstract][Full Text] [Related]
8. Syphilis mimetic nanoparticles for cuproptosis-based synergistic cancer therapy via reprogramming copper metabolism.
Zhang J; Han M; Zhang J; Abdalla M; Sun P; Yang Z; Zhang C; Liu Y; Chen C; Jiang X
Int J Pharm; 2023 Jun; 640():123025. PubMed ID: 37164186
[TBL] [Abstract][Full Text] [Related]
9. The use of pH-sensitive functional selenium nanoparticles shows enhanced in vivo VEGF-siRNA silencing and fluorescence imaging.
Yu Q; Liu Y; Cao C; Le F; Qin X; Sun D; Liu J
Nanoscale; 2014 Aug; 6(15):9279-92. PubMed ID: 24986368
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional siRNA-Laden Hybrid Nanoplatform for Noninvasive PA/IR Dual-Modal Imaging-Guided Enhanced Photogenetherapy.
Feng J; Yu W; Xu Z; Hu J; Liu J; Wang F
ACS Appl Mater Interfaces; 2020 May; 12(20):22613-22623. PubMed ID: 32338491
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil-Membrane-Coated Biomineralized Metal-Organic Framework Nanoparticles for Atherosclerosis Treatment by Targeting Gene Silencing.
Liu Y; He M; Yuan Y; Nie C; Wei K; Zhang T; Chen T; Chu X
ACS Nano; 2023 Apr; 17(8):7721-7732. PubMed ID: 37023215
[TBL] [Abstract][Full Text] [Related]
12. Layer by Layer Assembled Chitosan-Coated Gold Nanoparticles for Enhanced siRNA Delivery and Silencing.
Shaabani E; Sharifiaghdam M; De Keersmaecker H; De Rycke R; De Smedt S; Faridi-Majidi R; Braeckmans K; Fraire JC
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467656
[TBL] [Abstract][Full Text] [Related]
13. Silencing of Pyruvate Kinase M2
Huang S; Zhu W; Zhang F; Chen G; Kou X; Yang X; Ouyang G; Shen J
ACS Appl Mater Interfaces; 2021 Dec; 13(48):56972-56987. PubMed ID: 34797638
[TBL] [Abstract][Full Text] [Related]
14. Development of siRNA payloads to target KRAS-mutant cancer.
Yuan TL; Fellmann C; Lee CS; Ritchie CD; Thapar V; Lee LC; Hsu DJ; Grace D; Carver JO; Zuber J; Luo J; McCormick F; Lowe SW
Cancer Discov; 2014 Oct; 4(10):1182-1197. PubMed ID: 25100204
[TBL] [Abstract][Full Text] [Related]
15. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery.
Wang XL; Xu R; Lu ZR
J Control Release; 2009 Mar; 134(3):207-13. PubMed ID: 19135104
[TBL] [Abstract][Full Text] [Related]
16. Membrane Cholesterol Depletion Enhances Enzymatic Activity of Cell-Membrane-Coated Metal-Organic-Framework Nanoparticles.
Wang S; Kai M; Duan Y; Zhou Z; Fang RH; Gao W; Zhang L
Angew Chem Int Ed Engl; 2022 Jun; 61(24):e202203115. PubMed ID: 35395111
[TBL] [Abstract][Full Text] [Related]
17. Suppression of tumor growth in lung cancer xenograft model mice by poly(sorbitol-co-PEI)-mediated delivery of osteopontin siRNA.
Cho WY; Hong SH; Singh B; Islam MA; Lee S; Lee AY; Gankhuyag N; Kim JE; Yu KN; Kim KH; Park YC; Cho CS; Cho MH
Eur J Pharm Biopharm; 2015 Aug; 94():450-62. PubMed ID: 26141346
[TBL] [Abstract][Full Text] [Related]
18. Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes.
Jin M; Jin G; Kang L; Chen L; Gao Z; Huang W
Int J Nanomedicine; 2018; 13():2405-2426. PubMed ID: 29719390
[TBL] [Abstract][Full Text] [Related]
19. Iron-Oxide-Based Nanovector for Tumor Targeted siRNA Delivery in an Orthotopic Hepatocellular Carcinoma Xenograft Mouse Model.
Wang K; Kievit FM; Sham JG; Jeon M; Stephen ZR; Bakthavatsalam A; Park JO; Zhang M
Small; 2016 Jan; 12(4):477-87. PubMed ID: 26641029
[TBL] [Abstract][Full Text] [Related]
20. Overcoming cisplatin resistance in non-small cell lung cancer with Mad2 silencing siRNA delivered systemically using EGFR-targeted chitosan nanoparticles.
Nascimento AV; Singh A; Bousbaa H; Ferreira D; Sarmento B; Amiji MM
Acta Biomater; 2017 Jan; 47():71-80. PubMed ID: 27697601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
